How Genes Affect Healthy Life Years; Active Surveillance for Prostate Cancer
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 24, 2022 Category: Psychiatry Source Type: news

Treatment Works for Depression After Childhood Trauma
(MedPage Today) -- While patients with major depressive disorder and childhood trauma had more severe depressive symptoms, they benefited from treatment as much as those without childhood trauma, a meta-analysis found. A history of childhood trauma... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 23, 2022 Category: Psychiatry Source Type: news

How Durable Are Responses to Novel Antidepressant Zuranolone in MDD?
(MedPage Today) -- NEW ORLEANS -- A majority of patients with major depressive disorder (MDD) who responded to investigational zuranolone needed an additional course of therapy over the following year, according to findings from the ongoing... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 23, 2022 Category: Psychiatry Source Type: news

Sleep Experts Issue Advisory on Melatonin in Children
(MedPage Today) -- The American Academy of Sleep Medicine (AASM) issued a health advisory Wednesday encouraging parents to seek medical advice before giving melatonin or any supplement to children. "While melatonin can be useful in treating certain... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 22, 2022 Category: Psychiatry Source Type: news

Depression Treatment Failure Burdens Patients' Life and Wallets
(MedPage Today) -- NEW ORLEANS -- Depressed patients with prior treatment failure often face high medical costs and poor quality of life, a new survey suggested. Of 10,710 adults with self-reported major depressive disorder (MDD) who participated... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 21, 2022 Category: Psychiatry Source Type: news

USPSTF to Recommend Anxiety, Depression Screening
(MedPage Today) -- After pandemic years that brought mental health to the fore, the U.S. Preventive Services Task Force (USPSTF) is proposing to recommend screening adults for anxiety and depression, with one exception. In the group's draft recommendations... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 21, 2022 Category: Psychiatry Source Type: news

Comorbidities May Stall Diagnosis of PTSD in the General Population
(MedPage Today) -- NEW ORLEANS -- Patients with post-traumatic stress disorder (PTSD) are often treated for symptoms of the condition before ever receiving a formal diagnosis, according to a retrospective analysis of U.S. commercial claims data... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 21, 2022 Category: Psychiatry Source Type: news

How to Properly Counsel Patients Post-Roe
(MedPage Today) -- For 2 years I counseled patients seeking abortion care at a local independent clinic in Kentucky. It was an honor to help connect patients with the care they needed to achieve their goals for if, when, or how to grow their family... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 21, 2022 Category: Psychiatry Source Type: news

Depressive Symptoms in Moms Linked to Unhealthy Behaviors in Teens
(MedPage Today) -- Maternal depressive symptoms were associated with an increase in the number of unhealthy adolescent behaviors, a 15-year longitudinal study showed. While unhealthy behaviors were found to be common among adolescents in general... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 21, 2022 Category: Psychiatry Source Type: news

No Weird Dreams for Insomnia Patients Taking Lemborexant
(MedPage Today) -- NEW ORLEANS -- Abnormal dreams and nightmares were not common for insomnia patients treated with lemborexant (Dayvigo), according to two phase III clinical trials. Overall, few participants in the SUNRISE-1 (1.2%) and SUNRISE... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news

Low-Dose Cariprazine for MDD Tied to Anxiety Reduction
(MedPage Today) -- NEW ORLEANS -- Low-dose cariprazine (Vraylar) was associated with reductions in anxiety for patients with major depressive disorder (MDD), and the potential adjunctive therapy for this population also demonstrated improvements... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news

Gabapentin After Surgery Ups Risks in Older Adults
(MedPage Today) -- Perioperative gabapentin upped the risk of delirium, new antipsychotic use, and pneumonia in older adults after major surgery, a retrospective study showed. Risk of delirium -- the primary outcome of the study -- was 3.4... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news

Mental Health Issues Continue to Flow From Aftermath of Flint Water Crisis
(MedPage Today) -- Presumptive depression and post-traumatic stress disorder (PTSD) were highly prevalent among residents of Flint, Michigan, 5 years after they were exposed to contamination in their tap water, which was not declared safe until... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news

Trazodone Commonly Used Off-Label for Insomnia
(MedPage Today) -- NEW ORLEANS -- The antidepressant trazodone is no stranger to off-label use, especially for insomnia, a real-world study found. Among 1.4 million patients identified from U.S. medical and pharmacy claims data, over 100,000... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news

Rexulti Calms Alzheimer's Dementia-Related Agitation
(MedPage Today) -- NEW ORLEANS -- Brexpiprazole (Rexulti) helped ease agitation in people with Alzheimer's dementia, according to a phase III study. Over the course of the 12-week trial, patients on either a 2-mg or 3-mg daily dose of the atypical... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2022 Category: Psychiatry Source Type: news